Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yunnan Hongyao Capsule for Diabetic Distal Symmetrical Polyneuropathy
ChiCTR2300076675Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Xiamen University
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in diabetic peripheral polyneuropathy (DPN) comparing Control arm: mecobalamine + placebo with Experimental arm: mecobalamine + Yunnan Hongyao Capsule (2 arms). Primary endpoints: Traditional Chinese Medicine (TCM) symptom score, Toronto Clinical Scoring System (TCSS) and 2 more. Started Jan 2023; status: recruiting.
02
Drugs
Yunnan Hongyao Capsule
03
Conditions
diabetic peripheral polyneuropathy (DPN)
Beyond the preview
Go deeper on ChiCTR2300076675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300076675.